184 related articles for article (PubMed ID: 38500596)
1. XPA tumor variant leads to defects in NER that sensitize cells to cisplatin.
Blee AM; Gallagher KS; Kim HS; Kim M; Kharat SS; Troll CR; D'Souza A; Park J; Neufer PD; Schärer OD; Chazin WJ
NAR Cancer; 2024 Mar; 6(1):zcae013. PubMed ID: 38500596
[TBL] [Abstract][Full Text] [Related]
2. XPA tumor variants lead to defects in NER that sensitize cells to cisplatin.
Blee AM; Gallagher KS; Kim HS; Kim M; Troll CR; D'Souza A; Park J; Neufer PD; Schärer OD; Chazin WJ
bioRxiv; 2023 Jul; ():. PubMed ID: 37425789
[TBL] [Abstract][Full Text] [Related]
3. A truncated human xeroderma pigmentosum complementation group A protein expressed from an adenovirus sensitizes human tumor cells to ultraviolet light and cisplatin.
Rosenberg E; Taher MM; Kuemmerle NB; Farnsworth J; Valerie K
Cancer Res; 2001 Jan; 61(2):764-70. PubMed ID: 11212280
[TBL] [Abstract][Full Text] [Related]
4. New design of nucleotide excision repair (NER) inhibitors for combination cancer therapy.
Gentile F; Tuszynski JA; Barakat KH
J Mol Graph Model; 2016 Apr; 65():71-82. PubMed ID: 26939044
[TBL] [Abstract][Full Text] [Related]
5. Sensitization to the cytotoxicity of cisplatin by transfection with nucleotide excision repair gene xeroderma pigmentosun group A antisense RNA in human lung adenocarcinoma cells.
Wu X; Fan W; Xu S; Zhou Y
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5874-9. PubMed ID: 14676109
[TBL] [Abstract][Full Text] [Related]
6.
Li Q; Damish AW; Frazier Z; Liu D; Reznichenko E; Kamburov A; Bell A; Zhao H; Jordan EJ; Gao SP; Ma J; Abbosh PH; Bellmunt J; Plimack ER; Lazaro JB; Solit DB; Bajorin D; Rosenberg JE; D'Andrea AD; Riaz N; Van Allen EM; Iyer G; Mouw KW
Clin Cancer Res; 2019 Feb; 25(3):977-988. PubMed ID: 29980530
[TBL] [Abstract][Full Text] [Related]
7. Virtual screening and biological evaluation of inhibitors targeting the XPA-ERCC1 interaction.
Barakat KH; Jordheim LP; Perez-Pineiro R; Wishart D; Dumontet C; Tuszynski JA
PLoS One; 2012; 7(12):e51329. PubMed ID: 23272099
[TBL] [Abstract][Full Text] [Related]
8. [Enhancement effect of nucleotide excision repair gene xeroderma pigmentosun group a antisense RNA on sensitivity of human lung adenocarcinoma cell line A549 to cisplatin].
Fan W; Zhang HL; Wu XM
Ai Zheng; 2005 Apr; 24(4):403-7. PubMed ID: 15820060
[TBL] [Abstract][Full Text] [Related]
9. A disease-associated XPA allele interferes with TFIIH binding and primarily affects transcription-coupled nucleotide excision repair.
van den Heuvel D; Kim M; Wondergem AP; van der Meer PJ; Witkamp M; Lambregtse F; Kim HS; Kan F; Apelt K; Kragten A; González-Prieto R; Vertegaal ACO; Yeo JE; Kim BG; van Doorn R; Schärer OD; Luijsterburg MS
Proc Natl Acad Sci U S A; 2023 Mar; 120(11):e2208860120. PubMed ID: 36893274
[TBL] [Abstract][Full Text] [Related]
10. Nucleotide excision repair by mutant xeroderma pigmentosum group A (XPA) proteins with deficiency in interaction with RPA.
Saijo M; Takedachi A; Tanaka K
J Biol Chem; 2011 Feb; 286(7):5476-83. PubMed ID: 21148310
[TBL] [Abstract][Full Text] [Related]
11. Analysis of DNA binding by human factor xeroderma pigmentosum complementation group A (XPA) provides insight into its interactions with nucleotide excision repair substrates.
Sugitani N; Voehler MW; Roh MS; Topolska-Woś AM; Chazin WJ
J Biol Chem; 2017 Oct; 292(41):16847-16857. PubMed ID: 28860187
[TBL] [Abstract][Full Text] [Related]
12. Identification of a Synthetic Lethal Relationship between Nucleotide Excision Repair Deficiency and Irofulven Sensitivity in Urothelial Cancer.
Börcsök J; Sztupinszki Z; Bekele R; Gao SP; Diossy M; Samant AS; Dillon KM; Tisza V; Spisák S; Rusz O; Csabai I; Pappot H; Frazier ZJ; Konieczkowski DJ; Liu D; Vasani N; Rodrigues JA; Solit DB; Hoffman-Censits JH; Plimack ER; Rosenberg JE; Lazaro JB; Taplin ME; Iyer G; Brunak S; Lozsa R; Van Allen EM; Szüts D; Mouw KW; Szallasi Z
Clin Cancer Res; 2021 Apr; 27(7):2011-2022. PubMed ID: 33208343
[TBL] [Abstract][Full Text] [Related]
13. Expression of domains for protein-protein interaction of nucleotide excision repair proteins modifies cancer cell sensitivity to platinum derivatives and genomic stability.
Jordheim LP; Cros-Perrial E; Matera EL; Bouledrak K; Dumontet C
Clin Exp Pharmacol Physiol; 2014 Oct; 41(10):817-24. PubMed ID: 25115435
[TBL] [Abstract][Full Text] [Related]
14. Structural basis for the recruitment of ERCC1-XPF to nucleotide excision repair complexes by XPA.
Tsodikov OV; Ivanov D; Orelli B; Staresincic L; Shoshani I; Oberman R; Schärer OD; Wagner G; Ellenberger T
EMBO J; 2007 Nov; 26(22):4768-76. PubMed ID: 17948053
[TBL] [Abstract][Full Text] [Related]
15. Small Molecule Antagonists of the DNA Repair ERCC1/XPA Protein-Protein Interaction.
Obermann R; Yemane B; Jarvis C; Franco FM; Kyriukha Y; Nolan W; Gohara B; Krezel AM; Wildman SA; Janetka JW
ChemMedChem; 2024 Apr; 19(8):e202300648. PubMed ID: 38300970
[TBL] [Abstract][Full Text] [Related]
16. Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer.
Fleming ND; Agadjanian H; Nassanian H; Miller CW; Orsulic S; Karlan BY; Walsh CS
Cancer; 2012 Feb; 118(3):689-97. PubMed ID: 21751198
[TBL] [Abstract][Full Text] [Related]
17. Metal binding mediated conformational change of XPA protein:a potential cytotoxic mechanism of nickel in the nucleotide excision repair.
Hu J; Hu Z; Zhang Y; Gou X; Mu Y; Wang L; Xie XQ
J Mol Model; 2016 Jul; 22(7):156. PubMed ID: 27307058
[TBL] [Abstract][Full Text] [Related]
18. Cell cycle checkpoint abrogator UCN-01 inhibits DNA repair: association with attenuation of the interaction of XPA and ERCC1 nucleotide excision repair proteins.
Jiang H; Yang LY
Cancer Res; 1999 Sep; 59(18):4529-34. PubMed ID: 10493501
[TBL] [Abstract][Full Text] [Related]
19. Xeroderma pigmentosum group A protein loads as a separate factor onto DNA lesions.
Rademakers S; Volker M; Hoogstraten D; Nigg AL; Moné MJ; Van Zeeland AA; Hoeijmakers JH; Houtsmuller AB; Vermeulen W
Mol Cell Biol; 2003 Aug; 23(16):5755-67. PubMed ID: 12897146
[TBL] [Abstract][Full Text] [Related]
20. Transcription-coupled nucleotide excision repair as a determinant of cisplatin sensitivity of human cells.
Furuta T; Ueda T; Aune G; Sarasin A; Kraemer KH; Pommier Y
Cancer Res; 2002 Sep; 62(17):4899-902. PubMed ID: 12208738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
